DuPont is one of the world’s biggest chemical groups with businesses that include agriculture and industrial biotechnology.

In the fourth quarter, the company has published a net profit decreased by 0.8% to $ 373 million, or $0.35 per share. Analysts polled by Thomson Reuters expected an earning per share of $0.33. Revenue rose by 13.8% to $ 8.4 billion. However, Thomson Reuters’ consensus regularly downgraded EPS revisions (financials heading) from $4.3 to $ 4.2 right now.

Graphically, the stock has slowly increased until the USD 53.6 mid-term resistance. Since this test, the share is steadily crumbling, the 20-days moving average is a significant barrier and a crossing down of this one could cause share to break down.

In this context, investors could take a sell order at the current price to target USD 50. A stop loss should be fixed at USD 53.7.